HCA Healthcare (NYSE:HCA) Price Target Raised to $475.00 at KeyCorp

HCA Healthcare (NYSE:HCA) had its target price upped by KeyCorp from $465.00 to $475.00 in a research report report published on Monday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities research analysts also recently issued reports on HCA. Royal Bank Of Canada lowered their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. Robert W. Baird boosted their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Jefferies Financial Group boosted their price target on HCA Healthcare from $400.00 to $485.00 in a research report on Wednesday, October 15th. Truist Financial set a $460.00 target price on HCA Healthcare in a research report on Tuesday, October 14th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 7th. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $471.42.

HCA Healthcare Trading Up 4.8%

HCA Healthcare stock opened at $468.68 on Monday. The firm has a market capitalization of $109.67 billion, a P/E ratio of 18.12, a PEG ratio of 1.41 and a beta of 1.40. The stock has a fifty day moving average price of $416.33 and a 200 day moving average price of $383.23. HCA Healthcare has a 52 week low of $289.98 and a 52 week high of $469.18.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period in the prior year, the firm posted $4.90 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts predict that HCA Healthcare will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 11.13%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 1.30% of the stock is owned by insiders.

Institutional Trading of HCA Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Price T Rowe Associates Inc. MD raised its position in shares of HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares during the period. Viking Global Investors LP raised its position in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Goldman Sachs Group Inc. raised its position in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares during the period. Finally, Nuveen LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $569,217,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.